The Arc Two-component Signal Transduction System Inhibits in Vitro Escherichia coli Chromosomal Initiation*

Yong Sun LeeDagger, Joo Seok HanDagger, Yesu JeonDagger, and Deog Su Hwang§

From the Institute of Molecular Biology and Genetics, School of Biological Sciences, Seoul National University, Seoul 151-742, Korea

Received for publication, September 20, 2000, and in revised form, November 26, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Under anaerobic growth conditions, Escherichia coli operates a two-component signal transduction system, termed Arc, that consists of ArcB protein, a transmembrane sensor kinase and ArcA protein, the cognate response regulator. In response to low oxygen levels, autophosphorylated ArcB phosphorylates ArcA, and the resulting phosphorylated ArcA (ArcA-P) functions as a transcriptional regulator of the genes necessary to maintain anaerobic growth. Under anaerobic conditions, cells maintain a slow growth rate, suggesting that the initiation of chromosomal replication is regulated to reduce the initiation frequency. DNase I footprinting experiments revealed that ArcA-P binds to the left region of the chromosomal origin, oriC. ArcA-P did not affect the in vitro replication of plasmid DNA containing the ColE1 origin nor the in vitro replication of viral DNAs; however, ArcA-P specifically inhibited in vitro E. coli chromosomal replication. This inhibition was caused by the prevention of open complex formation, a necessary step in the initiation of chromosomal replication. Our in vitro results suggest that the Arc two-component system participates in regulating chromosomal initiation under anaerobic growth conditions.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Most organisms, including Escherichia coli, are able to adapt to variable growth conditions and environmental changes by regulating gene expression (1, 2). Adaptation in bacterial cells is usually achieved through two-component signal transduction systems, which consist of a sensor kinase and a response regulator (2, 3). The response regulator, phosphorylated by cognate sensor kinase in response to an external signal, serves as a transcriptional regulator optimizing gene expression under a given condition. In E. coli, the Arc (anoxic redox control) two-component signal transduction system operates in response to a shift from aerobiosis to anaerobiosis (4). The Arc signal transduction system consists of the ArcB and ArcA proteins, a transmembrane sensor kinase and its cognate response regulator, respectively (5, 6). In response to oxygen deficiency or redox change, ArcB autophosphorylates in an ATP-dependent manner and converts to phosphorylated ArcB (ArcB-P)1 via an intramolecular phospho-relay of His-292 right-arrow Asp-576 right-arrow His-717 (7). Subsequently, ArcB-P phosphorylates Asp-54 of ArcA, and the resulting ArcA-P (phosphorylated ArcA) functions as a transcriptional repressor for the sdh, gltA, lld, cyo, and sodA genes (4, 6, 8, 9) and as an activator for cyd, pfl, and traY genes (4, 8, 10, 11) to sustain anaerobic growth.

Anaerobic conditions that induce the Arc two-component signal transduction system lead to reduction in growth rate (12). Because the rate of chromosomal replication regulated mainly at the level of initiation is coupled to growth rate (13), the slow growth rate of E. coli during times of oxygen deficiency suggests that the frequency of chromosomal initiation is reduced. It is therefore probable that regulation of initiation occurs at oriC, the E. coli origin of chromosomal replication (14). This unique sequence, which is the highly conserved origin of Gram-negative bacteria (15), includes four DnaA boxes, AT-rich region containing three 13-mers, and an IHF binding site, all of which are required for proper chromosomal initiation of replication (16, 17). Binding of the initiator protein, DnaA, to the DnaA boxes leads to unwinding of the AT-rich regions and allows for the entry of DnaB helicase, a required step for subsequent initiation processes (18, 19). Opening of the AT-rich region is facilitated by the binding of IHF protein to the IHF site, thereby bending oriC (20, 21). Although IHF can be substituted by HU protein (21), in vivo footprinting experiments suggest that IHF may play a role in determining the timing of chromosomal initiation during the cell cycle (22).

Here we report that the binding of ArcA-P, phosphorylated by ArcB, to oriC results in the inhibition of chromosomal initiation. This result suggests that the Arc two-component signal transduction system plays a role in the regulation of chromosomal initiation at oriC in response to oxygen deficiency.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents and Proteins-- Sources were as follows: [gamma -32P]ATP (5000 Ci/mmol), [alpha -32P]dCTP (3000 Ci/mmol), and deoxynucleotides, Amersham Pharmacia Biotech; Long Ranger polyacrylamide, FMC BioProducts; DNase I, Life Technologies Inc.; nuclease P1, Roche Molecular Biochemicals; T4 polynucleotide kinase and Vent (exo-) DNA polymerase, New England BioLabs; calf intestinal alkaline phosphatase and restriction enzymes, Promega Corp. Unless indicated, reagents were purchased from Sigma Chemical Co.

Monomeric DnaA protein from HMS174 (pKC596) (23) and HU protein (24) were purified as previously described.

Bacterial Strains, Primers, and Plasmid and Phage DNAs-- E. coli strains MC1061 (25), W3110 (26), and WM433(dnaA204) (27) were previously described. E. coli DH5alpha (28) was used for isolation of plasmid DNA.

The DNAs were as follows: pFToriC (21) for DNase I footprinting; pSBoriC (29) for nuclease P1 assay; pBluescript SK(+) (Stratagene Corp.) for cloning; M13RE85 RF (replicative form) DNA (30), and single-stranded DNAs from phage G4 (31), M13mp19 (Stratagene Corp.), phi X174 (31) for in vitro complementation assays. For the construction of pBADarcA and pBADarcB, coding regions of arcA containing the whole polypeptide and arcB containing from the amino acid residue 129 to the stop codon were amplified using polymerase chain reaction and inserted into the EcoRI/HindIII site of pBAD18 (32) and the KpnI/XbaI site of pBAD24 (32), respectively.

Purification of ArcA and ArcB Proteins-- E. coli strain MC1061 harboring either pBADarcA or pBADarcB was grown in LB media to an OD at 595 nm of 0.5 followed by the addition of L(+)-arabinose to a concentration of 0.2% to induce overproduction of the proteins. 2 h after induction, cells were harvested, resuspended in cell resuspension buffer (25 mM HEPES-KOH (pH 7.6), 1 mM EDTA, and 2 mM dithiothreitol) to an OD at 595 nm of 200 and frozen in liquid nitrogen. Cell lysis and ammonium sulfate precipitation were performed as previously described (33), except that 0.37 g/ml ammonium sulfate instead of 0.28 g/ml was used. The pellet was resuspended in buffer A (25 mM HEPES-KOH (pH 7.8), 1 mM EDTA, 10% glycerol, and 2.86 mM 2-mercaptoethanol), which was used throughout the purification procedure. Subsequently, the activities of ArcA and ArcB were determined by transphosphorylation reactions as described below.

The resuspended ammonium sulfate-precipitated pellet containing ArcA protein was dialyzed to the conductivity equivalent of 50 mM KCl then subjected to FastQ column chromatography (60 ml of bed volume, Sigma) using 600 ml of a linear gradient ranging from 50 mM to 1 M KCl in buffer A. The fractions containing ArcA were pooled and dialyzed to the conductivity equivalent of 50 mM KCl then loaded onto a heparin-agarose column (12 ml of bed volume, Sigma). A 120-ml gradient ranging from 50 mM to 1 M KCl in buffer A was used for protein elution, with ArcA eluting at ~150 mM KCl. The fractions containing ArcA were pooled, diluted with buffer A to the conductivity equivalent of 50 mM KCl, and loaded onto a FastS column (4 ml of bed volume, Sigma). The fractions containing ArcA were pooled, diluted to the conductivity equivalent of 50 mM KCl with buffer A, and subjected to Cibacron Blue column chromatography (2.5 ml of bed volume, Sigma). A 25-ml gradient ranging from 50 mM to 2 M KCl in buffer A was run over the column, yielding near homogeneous ArcA, which eluted at ~0.5 M KCl. About 17 mg of ArcA protein was obtained from 15 liters culture of MC1061(pBADarcA).

For ArcB protein purification, the ammonium sulfate precipitate obtained from 6 liters of MC1061(pBADarcB) culture as described above was resuspended in buffer A, dialyzed to a conductivity equivalent of 50 mM KCl, and subjected to FastQ column chromatography (90 ml of bed volume) using a 900-ml gradient ranging from 50 mM to 1 M KCl in buffer A. Fractions containing ArcB were pooled, then dialyzed to a conductivity equivalent of 50 mM KCl and loaded onto a Cibacron blue column (17 ml of bed volume). A 170-ml gradient ranging from 50 mM to 1 M KCl in buffer A was run over the column. ArcB eluted in a broad range of fractions, which were pooled, and the protein was precipitated by the addition of 0.45 g/ml ammonium sulfate followed by centrifugation at 45,000 rpm for 30 min in a Ti70 rotor (Beckman). The pellet was resuspended with buffer A and subjected to Superose-12 gel filtration chromatography (Amersham Pharmacia Biotech, HR 10/30). ArcB eluted as a single peak. These fractions were pooled and loaded onto a MonoQ column (Amersham Pharmacia Biotech, HR 5/5). ArcB eluted from the MonoQ column at near homogeneity and was used in further experiments. A 6-liter culture of MC1061(pBADarcB) yielded about 9 mg of homogeneous ArcB.

Transphosphorylation Reaction-- Transphosphorylation reactions (TP), including purified ArcA and ArcB, were performed as previously described (34) with minor modifications. 10 µl of the TP mixture contained 6 µg each of ArcA and ArcB, 0.1 mM ATP, 70 mM KCl, 10 mM MgCl2, 33 mM HEPES-KOH (pH 7.4), 0.1 mM EDTA, and 2 mM dithiothreitol. After incubation at 32 °C for 10 min, the reaction mixture (2 µl per each assay unless indicated) was immediately used for further experiments.

To visualize the phosphorylated proteins, [gamma -32P]ATP was added to the above mixture. The reaction was terminated by addition of gel-loading buffer (10% glycerol, 3% SDS, 3% beta -mercaptoethanol, and 0.3% bromphenol blue). After incubation at 55 °C for 3 min, the mixture was subjected to 12% SDS-polyacrylamide gel electrophoresis. The gel was dried and visualized by autoradiography.

Phosphorylation reaction of ArcA with carbamyl phosphate (CP) was performed as previously described (35). 10 µl of the CP mixture containing the indicated amount of ArcA protein, 40 mM dilithium carbamyl phosphate,125 mM KCl, 10 mM MgCl2, and 100 mM Tris-HCl (pH 7.0) was incubated at 30 °C for 1 h and immediately used for experiments.

DNase I Protection Assays-- DNase I protection assays were performed as previously described (36) with minor modifications. A 435-bp XbaI/XhoI fragment from pFToriC was labeled at either the XhoI or XbaI restriction site. 21.5 fmol of labeled fragments was mixed with the indicated proteins in 25 µl of standard reaction mixture containing 0.1 mM ATP, 50 mM potassium chloride, 10 mM magnesium acetate, 2.5 µg of bovine serum albumin, 40 mM HEPES-KOH (pH 7.6), and 10% glycerol. After incubation at 32 °C for 10 min, DNase I (5 ng in 1.5 µl of H2O) was added, incubated for 30 s, then stopped by the addition of 27 µl of 0.6 M sodium acetate, 0.4% SDS, 25 mM EDTA, and 0.1 mg/ml yeast tRNA. Proteins were removed by phenol/chloroform extraction, and DNA was precipitated by ethanol, followed by a 70% ethanol wash. DNA was subjected to electrophoresis through a 5% Long Ranger polyacrylamide sequencing gel containing 7 M urea. The gel was dried and visualized by autoradiography.

In Vitro oriC Replication Assays-- As previously described (37, 38), in vitro oriC plasmid replication with fraction II from WM433 (dnaA204) and purified DnaA protein was performed using 200 ng of M13RE85 RF DNA as a template.

Single-stranded phage DNAs, such as G4, M13mp19, and phi X174, and pBluescript containing the ColE1 replication origin, 200 ng each, were used for DnaA-independent replication. In these assays, all conditions were identical to oriC plasmid replication reactions, except that DnaA was omitted.

Open Complex Formation and P1 Nuclease Assay-- Open complex formation at oriC was detected using single-strand specific P1 nuclease as previously described with modifications (21, 39). 25 µl of opening reaction mixture containing the indicated amount of DnaA, 15 ng of HU, 200 ng of supercoiled pSBoriC, 4 mM ATP, 50 mM potassium glutamate, 2.5 mM magnesium acetate, 2.5 µg of bovine serum albumin, 40 mM HEPES-KOH (pH 7.6), and 17% glycerol, was incubated at 37 °C for 5 min. Then 3 units of P1 nuclease in 3 µl of 30 mM sodium acetate (pH 5.2) was added and incubated at 37 °C for 30 s. The cleavage reaction was quenched by the addition of 27 µl of stop solution (25 mM EDTA, 0.4 M NaOH). After incubation at room temperature for 10 min, followed by addition of 6 µl of 3 M sodium acetate (pH 5.2), proteins were removed by phenol/chloroform extraction. With 2.5 µg of yeast tRNA as a carrier for precipitation, DNA samples were collected by ethanol precipitation followed by a 70% ethanol wash. The precipitated DNA was resuspended with 6 µl of H2O, and 2 µl was taken to be used as template for primer extension reactions. 6 µl of the primer extension mixture included 1.25 nmol of each dNTP, 0.25 pmol of 5'-end-labeled primer PA1 (21), and 0.42 unit of Vent (exo-) DNA polymerase in Vent (exo-) buffer with 5 mM MgSO4. The primer was 5'-end-labeled with [gamma -32P]ATP and T4 polynucleotide kinase; unincorporated radioactivity was removed using a Bio-Gel 6 spin column (Bio-Rad). The mixture was subjected to primer extension reactions in a thermocycler, for 20 cycles (95 °C for 1 min except for 4 min in the first cycle, 55 °C for 1 min, and 72 °C for 1 min except for 6 min in the last cycle). The reaction was stopped by the addition of 4 µl of sequencing gel loading buffer, then subjected to electrophoresis through a 5% Long Ranger polyacrylamide sequencing gel containing 7 M urea. The gel was dried and visualized by autoradiography.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

ArcA-P Protein Binds to oriC-- To investigate the interaction of ArcA and ArcB with oriC DNA, ArcA and ArcB proteins were overproduced and purified to near homogeneity using column chromatography (Fig. 1A). Due to poor expression of the ArcB protein, we instead expressed and purified a truncated ArcB lacking the N terminus from amino acid residues from 1 to 128 as described previously (34). The ArcA and ArcB proteins used in this study were distinctive from the proteins containing the hexa-histidine (7, 35, 40, 41) or renatured from SDS-polyacrylamide gels (34) as used in previous studies. The purified ArcA and ArcB proteins were active in transphosphorylation reactions. In the presence of ATP, ArcB underwent autophosphorylation and subsequently transferred the phosphoryl group from itself to ArcA, forming ArcA-P, whereas ArcA alone was not phosphorylated (Fig. 1B).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 1.   Phosphorylation of ArcA by ArcB. A, 3 µg each of purified ArcB and ArcA were run on SDS-polyacrylamide gel electrophoresis and visualized after staining with Coomassie Blue. B, transphosphorylation reactions with the indicated proteins and [gamma -32P]ATP were performed as described under "Materials and Methods." Phosphorylated proteins were visualized by autoradiography. M indicates molecular mass markers as kDa.

Binding of the transphosphorylation mixture (TP mixture), which contains ArcA, ArcB, and ATP, to the oriC region of the E. coli chromosome was detected using a DNase I protection assay (Fig. 2). Increasing the amount of TP mixture added to the footprinting reaction revealed that an ~150-bp region located at the left end of oriC, including the three 13-mer AT-rich regions, DnaA box R1, and IHF binding site, was protected from DNase I cleavage (Fig. 2). The omission of ArcA, ArcB, or both from the TP mixture abolished the protection pattern observed at oriC, indicating that the oriC binding activity requires both ArcA and ArcB proteins.


View larger version (95K):
[in this window]
[in a new window]
 
Fig. 2.   Binding of Arc to the left half of oriC. DNase I protection assays were performed with the XbaI/XhoI fragment 5'-end-labeled at the XbaI site (A) or XhoI site (B) as described under "Materials and Methods." Unless indicated, 2 µl of the TP mixture was used for assays. Lane 1, free DNA; lanes 2-4, 2 µl of the TP mixture with the indicated proteins; lanes 5-8, 0.25, 0.5, 1, and 2 µl of the TP mixture containing both ArcB and ArcA. The locations of three AT-rich 13-mers (LMR), four DnaA boxes (R1-R4), and the IHF binding site (IHF) in oriC are indicated to the left of the figure. A, G, C, and T indicate dideoxy sequencing of pFToriC. The numbers to the right correspond to the numbers of the oriC nucleotide sequence (17).

Neither ADP nor the nonhydrolyzable ATP-analogue AMPPNP was able to substitute ATP for the oriC protection activity of the TP mixture, implying the requirement of ATP hydrolysis for binding (Fig. 3A). Efficient oriC protection activity required more than 50 µM ATP. Without ArcB and ATP, it has been shown that the phosphoryl group donors carbamyl phosphate and acetyl phosphate can phosphorylate ArcA (35). Therefore, we incubated ArcA with carbamyl phosphate in the absence of ArcB and ATP, and found an identical DNase I cleavage protection pattern (Fig. 3B). These results indicate that ArcA-P, produced by phosphorylation of ArcA protein either by ArcB and ATP or by carbamyl phosphate, binds to the left end of oriC.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 3.   Binding of ArcA-P to the oriC. DNase I protection assays were performed using the XbaI/XhoI fragment 5'-end-labeled at the XhoI site as described in Fig. 2 and "Materials and Methods." A, lane 1, free DNA; lane 2, TP mixture without nucleotide; lanes 3 and 4, TP mixture containing 100 µM each of ADP and AMPPNP respectively; lanes 5-7, TP mixture containing 100, 50, and 25 µM ATP. The same concentrations of each nucleotide was included in footprinting reaction. B, instead of ArcB and ATP, 40 mM carbamyl phosphate was added in 10 µl of CP mixture containing 3 µg of ArcA. Lane 1, free DNA; lane 2-4, 0.5, 1, and 2 µl of CP mixture containing ArcA and carbamyl phosphate; lane 5, 2 µl of CP mixture containing ArcA alone. CP indicates carbamyl phosphate.

ArcA-P Inhibits in Vitro oriC-dependent Initiation of Chromosomal Replication-- The AT-rich regions and DnaA box R1 found at oriC are indispensable for both in vitro and in vivo initiation of chromosomal replication (18, 29, 42). Therefore, the effect of ArcA-P, which was found to bind those regions of oriC, on chromosomal initiation was examined using an in vitro oriC plasmid replication assay (37, 38). This assay resembles in vivo chromosomal initiation in many aspects, including dependence upon the oriC sequence, requirement of replicative proteins, and bidirectional replication from oriC (37, 43).

Addition of purified DnaA protein to the oriC plasmid replication assay sustained the replication of oriC plasmid M13RE85 RF DNA, in which the oriC region has been inserted into M13mp8 RF DNA (Fig. 4A). The presence of the TP mixture in the assay, however, inhibited DnaA-dependent oriC plasmid replication. Omission of ArcA, ArcB, or both from the TP mixture eliminated the inhibitory activity of the TP mixture (Fig. 4B), indicating that the inhibitory activity is dependent on both ArcA and ArcB. However, incubation of ArcA protein with carbamyl phosphate instead of ArcB and ATP also inhibited oriC plasmid replication, whereas carbamyl phosphate or ArcA alone was not inhibitory (Fig. 4C). These results imply that ArcA-P, formed either by ArcB and ATP or by carbamyl phosphate, inhibits the oriC plasmid replication, and ArcB is not a requirement.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Inhibition of in vitro oriC replication by ArcA-P. In vitro DNA replication assays with oriC plasmid M13RE85 RF DNA (A-C) or indicated DNAs (D) were performed as described under "Materials and Methods." A, in the presence (+TP) or absence (-TP) of 2 µl of TP mixture, the indicated amount of DnaA was added to each oriC replication assay. B, TP mixture or TP mixture with indicated proteins omitted were titrated in oriC replication assays containing 100 ng of DnaA protein. C, CP mixture containing 6 µg of ArcA, 40 mM carbamyl phosphate, or both, was titrated in oriC replication assays containing 100 ng of DnaA. D, TP mixture was titrated in replication assay containing the indicated single-stranded DNAs or plasmid DNA.

To determine whether ArcA-P specifically inhibits initiation at oriC, the effect of ArcA-P on other origins was studied. Single-stranded viral DNAs phi X174, M13, and G4 replicate from single- to double-stranded RF DNA using unique initiation processes, with each viral origin using varying proteins (16). In the absence of DnaA, the soluble proteins of fraction II, used for oriC plasmid replication, are sufficient to replicate single-stranded viral DNAs to RF DNAs (37). Plasmid pBluescript, which contains the ColE1 origin, can also be replicated by fraction II in the absence of DnaA, but with less efficiency than the DnaA-dependent replication of oriC plasmid DNAs (37). Addition of the TP mixture to these reactions did not affect replication of any of the tested single-stranded viral DNAs or pBluescript DNA (Fig. 4D), indicating that ArcA-P specifically inhibits the initiation of replication at oriC.

ArcA-P Does Not Affect the Binding of DnaA and IHF Protein to oriC-- Because DNase I footprinting revealed the binding region of ArcA-P at a 150-bp region of the left end of oriC containing both DnaA box R1 and the IHF binding site, DNase I footprinting was further performed to determine whether ArcA-P inhibits initiation of replication at oriC by blocking the interaction of DnaA or IHF with oriC (Fig. 5). Addition of increasing amounts of DnaA to oriC (Fig. 5A, lanes 2-4) resulted in the protection of DnaA boxes R1 to R4 and IHF bound to the IHF binding site (Fig. 5B, lanes 2-4) both as previously described (21). DnaA and IHF added prior to or after ArcA-P did not allow the binding of ArcA-P to DnaA box R1 nor the IHF site, respectively; however, neither protein affected the binding of ArcA-P to the AT-rich region (Fig. 5, A and B, lanes 5-11). These results indicate that the binding of DnaA to DnaA box R1 and IHF to the IHF site is preferred over the binding of ArcA-P to those sites. However, DnaA and IHF do not affect ArcA-P binding to the AT-rich region.


View larger version (120K):
[in this window]
[in a new window]
 
Fig. 5.   Binding of ArcA-P, DnaA protein, IHF, and IciA protein to oriC. DNase I protection assays were performed with the XbaI/XhoI fragment 5'-end-labeled at the XbaI site (A) or XhoI site (B) as described under "Materials and Methods." Lane 1, free DNA; lanes 2-4, 25, 50, 100 ng of DnaA protein (A) or 15, 30, 60 ng of IHF (B); lanes 5-6, 100 ng of DnaA (A) or 60 ng of IHF (B) followed by addition of 0.5 and 1 µl of TP mixture; lanes 7-8, 0.5 and 1 µl of TP mixture; lanes 9-11, 1 µl of TP mixture followed by addition of 25, 50, and 100 ng of DnaA protein (A) or 15, 30, and 60 ng of IHF; lane 12, 600 ng of ArcA followed by addition of 100 ng of DnaA (A) or 60 ng of IHF (B); lane 13, 600 ng of ArcB followed by addition of 100 ng of DnaA (A) or 60 ng of IHF (B); lane 14, 1 µl of TP mixture followed by addition of 75 ng of IciA protein; lane 15, 75 ng of IciA protein; lane 16, 75 ng of IciA protein followed by addition of 1 µl of TP mixture

To further study the binding of ArcA-P to the AT-rich region of oriC, competition experiments using IciA were performed. IciA protein specifically binds to the three 13-mers in the AT-rich region and inhibits the initiation stage of in vitro oriC replication (52). Interestingly, addition of IciA to a preformed ArcA-P·oriC complex displaced ArcA-P to generate a footprint similar that of IciA only. Conversely, ArcA-P displaced IciA bound to oriC (Fig. 5B, lanes 14-16).

ArcA-P Blocks Open Complex Formation in oriC-dependent Initiation-- At the onset of initiation, DnaA protein unwinds the AT-rich regions of oriC with the aid of HU or IHF, forming the open complex, a step that is prerequisite for the subsequent stages of initiation (18, 19). DnaA-dependent strand opening of the AT-rich region can be observed using single-stranded-specific P1 nuclease and primer extension assays (Fig. 6), as previously described (21, 39). Addition of the TP mixture prior to DnaA protein in the assays resulted in inhibition of open complex formation. However, the addition of the TP mixture after open complex formation did not significantly inhibit open complex formation. These results imply that ArcA-P functions prior to the DnaA-dependent strand opening of the AT-rich region. The amounts of TP mixture required for oriC binding (Fig. 2), inhibition of oriC replication (Fig. 4B), and inhibition of open complex formation (Fig. 6) were comparable to each other. These results suggest that binding of ArcA-P to oriC inhibits oriC initiation by blocking open complex formation.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 6.   Inhibition of open complex formation by ArcA-P. P1 nuclease cleavage and primer extension assays were performed as described under "Materials and Methods." In A: lanes 1-4, the indicated amount of DnaA was added to the opening reaction; lanes 5-8, TP mixture was added after open complex formation, then incubated 5 min more; lanes 9-11, TP mixture, instead of DnaA, was added to the open complex formation reaction, incubated for 5 min, followed by addition of DnaA and another 5-min incubation. In B: The extent of P1 cleavage at the 13-mer M in A was measured using a FUJIX Bio-Imaging Analyzer (BAS 1000) and normalized to the value of lane 5.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

ArcA protein phosphorylated by ArcB and ATP or by carbamyl phosphate binds the left end of oriC. This bound region includes the AT-rich 13-mers, DnaA box R1, and the IHF binding site, regions all highly conserved in chromosomal replication origins of Gram-negative bacteria (15) and all of which are essential for initiation of E. coli chromosomal replication (18, 29, 42). In chromosomal initiation events, the AT-rich region of oriC is unwound upon binding of DnaA proteins to the DnaA boxes (18, 19). Interaction of DnaA protein with the AT-rich region, leading to strand opening, is facilitated by the bending of oriC by IHF protein bound to the IHF site (20, 21). Binding of ArcA-P blocks DnaA-dependent strand opening of the AT-rich regions (Fig. 6), a step required for subsequent stages of chromosomal initiation to occur. Binding of ArcA-P also results in the inhibition of in vitro oriC plasmid replication (Fig. 4). Because ArcA-P does not appear to affect the binding of DnaA and IHF to their loci (Fig. 5), such inhibition may be caused by ArcA-P binding to the AT-rich regions of oriC, thereby inhibiting a proper interaction between DnaA protein and the AT-rich region, an interaction which is thought to be required for the opening of the AT-rich region by DnaA (29, 44).

Aside from our reported binding of ArcA-P to oriC, ArcA-P binds to a number of promoter regions (35, 44-46), including the pfl promoter that controls expression of pyruvate formate lyase (46). We observed that ArcA-P possessed similar affinities to the oriC and pfl promoters using gel-shift assays (data not shown). However, we could not match the suggested ArcA-P binding consensus sequence (49) with the oriC sequences, the only commonality we found was a richness of A and T. Although unphosphorylated ArcA binds to pfl and sodA promoter regions in a several- to 10-fold excess over ArcA-P, with the same pattern of ArcA-P binding (46, 47), we could not detect any binding of unphosphorylated ArcA to oriC, even when using a 15- to 20-fold excess (up to 15 µM) as compared with ArcA-P in the DNase I footprinting assay (data not shown). ArcA-P, even with a molecular mass of 27 kDa, protected a wide region, ~150 bp, of oriC from DNase I cleavage (Figs. 2 and 3). This broad binding pattern was also observed at other ArcA-P binding sites (35, 46, 48). The increased amount of ArcA-P enhanced the intensity of protected regions, rather than resulting in the broadening of the bound region, which would be evident if sequential bindings of ArcA-P were taking place (Fig. 2). These binding patterns suggest that multimerized or oligomerized ArcA-P, formed prior to DNA binding, as suggested from other binding sites (35, 46, 47), may bind to the left half of oriC. The DNase I-hypersensitive sites with ~10-bp intervals (Figs. 2 and 3) suggest that multimerized ArcA-P wraps the left end of oriC.

Chromosomal replication is regulated mainly at the level of initiation; the rate of chromosomal replication is coupled to growth rate (13). Different physiological conditions determine unique growth rates, reflected by the frequency of chromosomal initiation. Slow growth conditions require a reduction in the frequency of chromosomal initiations to meet the retarded growth. However, it has been scarcely documented how organisms set the initiation frequency in response to various physiological conditions or environmental stresses. In E. coli, it was reported that UV irradiation inhibits the initiation of chromosomal replication from oriC (50), however, there are no further studies showing the regulatory factors involved or underlying mechanisms.

The pleiotrophic effects of arcA mutations (4-6, 41, 51, 52) present challenges in performing in vivo experiments and make interpretation of the results difficult. Even under aerobic condition, arcA mutants possess reduced chromosome numbers compared with the wild type (data not shown). Although there is no clear in vivo data available, our in vitro results suggest that Arc, a two-component signal transduction system operated under anaerobic conditions in E. coli, plays a role in regulation of chromosomal initiation. Under oxygen depletion stress, the response regulator ArcA, phosphorylated by sensor kinase ArcB, may bind to oriC and reduce chromosomal initiation.

    ACKNOWLEDGEMENTS

We thank Dr. Edmund C. C. Lin and Dr. Ohsuk Kwon for helpful discussions and Gillian Newman for careful editing of this manuscript.

    FOOTNOTES

* This work was supported in part by the Basic Research Program of Korea Science and Engineering Foundation (Grant 1999-1-209-004-5) and by a grant from Life Phenomena and Function Research of Korea Institute of Science and Technology Evaluation and Planning.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by a BK21 Research Fellowship from the Korean Ministry of Education.

§ To whom correspondence should be addressed: Tel.: 82-2-880-7524; Fax: 82-2-874-1206; E-mail: dshwang@plaza.snu.ac.kr.

Published, JBC Papers in Press, December 22, 2000, DOI 10.1074/jbc.M008629200

    ABBREVIATIONS

The abbreviations used are: ArcB-P, phosphorylated ArcB; ArcA-P, phosphorylated ArcA; CP mixture, phosphorylation mixture containing carbamyl phosphate; RF, replicative form; TP mixture, transphosphorylation reaction mixture; bp, base pair(s); AMPPNP, adenosine 5'-(beta ,gamma -methylenetriphosphate).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Parkinson, J. S. (1995) in Two-component Signal Transduction (Hoch, J. A. , and Silhavy, T. J., eds) , pp. 9-23, American Society for Microbiology, Washington, DC
2. Ninfa, A. J. (1996) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C. , Curtiss, R., III , Ingraham, J. L. , Lin, E. C. C. , Low, K. B. , Magasanik, B. , Reznikoff, W. S. , Riley, M. , Schaechter, M. , and Umbarger, H. E., eds), 2nd Ed., Vol. 1 , pp. 1246-1262, American Society for Microbiology, Washington DC
3. Stock, J. B., Stock, A. M., and Mottonen, J. M. (1990) Nature 344, 395-400[CrossRef][Medline] [Order article via Infotrieve]
4. Lynch, A. S., and Lin, E. C. C. (1996) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C. , Curtiss, R., III , Ingraham, J. L. , Lin, E. C. C. , Low, K. B. , Magasanik, B. , Reznikoff, W. S. , Riley, M. , Schaechter, M. , and Umbarger, H. E., eds), 2nd Ed., Vol. 1 , pp. 1526-1538, American Society for Microbiology, Washington DC
5. Iuchi, S., Cameron, D. C., and Lin, E. C. (1989) J. Bacteriol. 171, 868-873[Medline] [Order article via Infotrieve]
6. Iuchi, S., Cameron, D. C., and Lin, E. C. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1888-1892[Abstract]
7. Georgellis, D., Lynch, A. S., and Lin, E. C. (1997) J. Bacteriol. 179, 5429-5435[Abstract]
8. Iuchi, S., Chepuri, V., Fu, H. A., Gennis, R. B., and Lin, E. C. (1990) J. Bacteriol. 172, 6020-6025[Medline] [Order article via Infotrieve]
9. Tardat, B., and Touati, D. (1991) Mol. Microbiol. 5, 455-465[Medline] [Order article via Infotrieve]
10. Sawers, G., and Suppmann, B. (1992) J. Bacteriol. 174, 3474-3478[Abstract]
11. Silverman, P. M., Wickersham, E., and Harris, R. (1991) J. Mol. Biol. 218, 119-128[Medline] [Order article via Infotrieve]
12. Iuchi, S., Aristarkhov, A., Dong, J. M., Taylor, J. S., and Lin, E. C. (1994) J. Bacteriol. 176, 1695-1701[Abstract]
13. von Meyenburg, K., and Hansen, F. G. (1987) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C. , Ingraham, J. L. , Low, K. B. , Magasanik, B. , Schaechter, M. , and Umbarger, H. E., eds), Vol. 2 , pp. 1555-1577, American Society for Microbiology, Washington DC
14. Oka, A., Sugimoto, K., Takanami, M., and Hirota, Y. (1980) Mol. Gen. Genet. 178, 9-20[Medline] [Order article via Infotrieve]
15. Zyskind, J. W., Cleary, J. M., Brusilow, W. S., Harding, N. E., and Smith, D. W. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 1164-1168[Abstract]
16. Kornberg, A., and Baker, T. A. (1992) DNA Replication , 2nd Ed. , pp. 521-533, W. H. Freeman and Co., New York
17. Messer, W., and Weigel, C. (1996) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C. , Curtiss, R., III , Ingraham, J. L. , Lin, E. C. C. , Low, K. B. , Magasanik, B. , Reznikoff, W. S. , Riley, M. , Schaechter, M. , and Umbarger, H. E., eds), 2nd Ed., Vol. 2 , pp. 1579-1601, American Society for Microbiology, Washington DC
18. Bramhill, D., and Kornberg, A. (1988) Cell 52, 743-755[Medline] [Order article via Infotrieve]
19. Bramhill, D., and Kornberg, A. (1988) Cell 54, 915-918[Medline] [Order article via Infotrieve]
20. Polaczek, P. (1990) New Biol. 2, 265-271[Medline] [Order article via Infotrieve]
21. Hwang, D. S., and Kornberg, A. (1992) J. Biol. Chem. 267, 23083-23086[Abstract/Free Full Text]
22. Cassler, M. R., Grimwade, J. E., and Leonard, A. C. (1995) EMBO J. 14, 5833-5841[Abstract]
23. Carr, K. M., and Kaguni, J. M. (1996) Mol. Microbiol. 20, 1307-1318[Medline] [Order article via Infotrieve]
24. Kaguni, J. M., and Kornberg, A. (1984) Cell 38, 183-190[Medline] [Order article via Infotrieve]
25. Johnston, S., Lee, J. H., and Ray, D. S. (1985) Gene 34, 137-145[CrossRef][Medline] [Order article via Infotrieve]
26. Bachmann, B. J. (1972) Bacteriol. Rev. 36, 525-557[Medline] [Order article via Infotrieve]
27. Beyersmann, D., Messer, W., and Schlicht, M. (1974) J. Bacteriol. 118, 783-789[Medline] [Order article via Infotrieve]
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
29. Hwang, D. S., and Kornberg, A. (1992) J. Biol. Chem. 267, 23087-23091[Abstract/Free Full Text]
30. Baker, T. A., and Kornberg, A. (1988) Cell 55, 113-123[Medline] [Order article via Infotrieve]
31. Stayton, M. M., and Kornberg, A. (1983) J. Biol. Chem. 258, 13205-13212[Abstract/Free Full Text]
32. Guzman, L. M., Belin, D., Carson, M. J., and Beckwith, J. (1995) J. Bacteriol. 177, 4121-4130[Abstract]
33. Hwang, D. S., and Kaguni, J. M. (1988) J. Biol. Chem. 263, 10625-10632[Abstract/Free Full Text]
34. Iuchi, S., and Lin, E. C. (1992) J. Bacteriol. 174, 5617-5623[Abstract]
35. Lynch, A. S., and Lin, E. C. (1996) J. Bacteriol. 178, 6238-6249[Abstract]
36. Lee, Y. S., Kim, H., and Hwang, D. S. (1996) Mol. Microbiol. 19, 389-396[Medline] [Order article via Infotrieve]
37. Fuller, R. S., Kaguni, J. M., and Kornberg, A. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 7370-7374[Abstract]
38. Fuller, R. S., and Kornberg, A. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 5817-5821[Abstract]
39. Torheim, N. K., and Skarstad, K. (1999) EMBO J. 18, 4882-4888[Abstract/Free Full Text]
40. Colloms, S. D., Alen, C., and Sherratt, D. J. (1998) Mol. Microbiol. 28, 521-530[CrossRef][Medline] [Order article via Infotrieve]
41. Strohmaier, H., Noiges, R., Kotschan, S., Sawers, G., Hogenauer, G., Zechner, E. L., and Koraimann, G. (1998) J. Mol. Biol. 277, 309-316[CrossRef][Medline] [Order article via Infotrieve]
42. Asai, T., Takanami, M., and Imai, M. (1990) EMBO J. 9, 4065-4072[Abstract]
43. Kaguni, J. M., Fuller, R. S., and Kornberg, A. (1982) Nature 296, 623-627[Medline] [Order article via Infotrieve]
44. Yung, B. Y., and Kornberg, A. (1989) J. Biol. Chem. 264, 6146-6150[Abstract/Free Full Text]
45. Drapal, N., and Sawers, G. (1995) Mol. Microbiol. 16, 597-607[Medline] [Order article via Infotrieve]
46. Tardat, B., and Touati, D. (1993) Mol. Microbiol. 9, 53-63[Medline] [Order article via Infotrieve]
47. Pellicer, M. T., Fernandez, C., Badia, J., Aguilar, J., Lin, E. C., and Baldom, L. (1999) J. Biol. Chem. 274, 1745-1752[Abstract/Free Full Text]
48. McGuire, A. M., De Wulf, P., Church, G. M., and Lin, E. C. (1999) Mol. Microbiol. 32, 219-221[Medline] [Order article via Infotrieve]
49. Verma, M., Moffat, K. G., and Egan, J. B. (1989) Mol. Gen. Genet. 216, 446-454[Medline] [Order article via Infotrieve]
50. Iuchi, S., Furlong, D., and Lin, E. C. (1989) J. Bacteriol. 171, 2889-2893[Medline] [Order article via Infotrieve]
51. Nystrom, T., Larsson, C., and Gustafsson, L. (1996) EMBO J. 15, 3219-3228[Abstract]
52. Hwang, D. S., and Kornberg, A. (1990) Cell 63, 325-331[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.